Erenumab and OnabotulinumtoxinA in Chronic Migraine: A Comparative Analysis.

Garcés-Pellejero M, Torres-Ferrús M, Mas-de-Les-Valls R, Caronna E, Alpuente A, Giné-Ciprés E, Pozo-Rosich P

Open source

DOI
10.1111/ene.70654
Published
2026 Jun
Container
European journal of neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/ene.70654,
  title = {Erenumab and OnabotulinumtoxinA in Chronic Migraine: A Comparative Analysis.},
  author = {Garcés-Pellejero M and Torres-Ferrús M and Mas-de-Les-Valls R and Caronna E and Alpuente A and Giné-Ciprés E and Pozo-Rosich P},
  year = {2026},
  journal = {European journal of neurology},
  doi = {10.1111/ene.70654},
  url = {https://doi.org/10.1111/ene.70654}
}

RIS

TY  - JOUR
TI  - Erenumab and OnabotulinumtoxinA in Chronic Migraine: A Comparative Analysis.
AU  - Garcés-Pellejero M
AU  - Torres-Ferrús M
AU  - Mas-de-Les-Valls R
AU  - Caronna E
AU  - Alpuente A
AU  - Giné-Ciprés E
AU  - Pozo-Rosich P
PY  - 2026
JO  - European journal of neurology
DO  - 10.1111/ene.70654
UR  - https://doi.org/10.1111/ene.70654
ER  - 

APA

M, G., M, T., R, M., E, C., A, A., E, G., & P, P. (2026). Erenumab and OnabotulinumtoxinA in Chronic Migraine: A Comparative Analysis.. European journal of neurology. https://doi.org/10.1111/ene.70654

Source records